Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer

Esmee Koedoot, Dieudonné J. van der Meer, Anne M. van Altena, Lieke J. Ceton, Timothy J. P. Sijsenaar, Marta G. Montero, Fanny Grillet, Jurgen M. J. Piek, Ruud L. M. Bekkers, Maurice J. D. L. van der Vorst, Auke M. T. Huijben, Astrid Baalbergen, Kevin G. J. A. Voogdt, Loes Verhoeven, Huberdina P. M. Smedts, Klaus Weber, Hans Marten Hazelbag, Tjalling Bosse, Els L. van Persijn-van Meerten, Cornelis D. de Kroon, Leo Price, Willemijn Vader, Judith R. Kroep, Nelleke P. B. Ottevanger

Open source

DOI: 10.1038/s41698-025-01080-8
Published: 2025-08-30
Container: npj Precision Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-025-01080-8,
  title = {Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer},
  author = {Esmee Koedoot and Dieudonné J. van der Meer and Anne M. van Altena and Lieke J. Ceton and Timothy J. P. Sijsenaar and Marta G. Montero and Fanny Grillet and Jurgen M. J. Piek and Ruud L. M. Bekkers and Maurice J. D. L. van der Vorst and Auke M. T. Huijben and Astrid Baalbergen and Kevin G. J. A. Voogdt and Loes Verhoeven and Huberdina P. M. Smedts and Klaus Weber and Hans Marten Hazelbag and Tjalling Bosse and Els L. van Persijn-van Meerten and Cornelis D. de Kroon and Leo Price and Willemijn Vader and Judith R. Kroep and Nelleke P. B. Ottevanger},
  year = {2025},
  journal = {npj Precision Oncology},
  doi = {10.1038/s41698-025-01080-8},
  url = {https://doi.org/10.1038/s41698-025-01080-8}
}

RIS

TY  - JOUR
TI  - Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer
AU  - Esmee Koedoot
AU  - Dieudonné J. van der Meer
AU  - Anne M. van Altena
AU  - Lieke J. Ceton
AU  - Timothy J. P. Sijsenaar
AU  - Marta G. Montero
AU  - Fanny Grillet
AU  - Jurgen M. J. Piek
AU  - Ruud L. M. Bekkers
AU  - Maurice J. D. L. van der Vorst
AU  - Auke M. T. Huijben
AU  - Astrid Baalbergen
AU  - Kevin G. J. A. Voogdt
AU  - Loes Verhoeven
AU  - Huberdina P. M. Smedts
AU  - Klaus Weber
AU  - Hans Marten Hazelbag
AU  - Tjalling Bosse
AU  - Els L. van Persijn-van Meerten
AU  - Cornelis D. de Kroon
AU  - Leo Price
AU  - Willemijn Vader
AU  - Judith R. Kroep
AU  - Nelleke P. B. Ottevanger
PY  - 2025
JO  - npj Precision Oncology
DO  - 10.1038/s41698-025-01080-8
UR  - https://doi.org/10.1038/s41698-025-01080-8
ER  -

APA

Koedoot, E., Meer, D. J. V. D., Altena, A. M. V., Ceton, L. J., Sijsenaar, T. J. P., Montero, M. G., Grillet, F., Piek, J. M. J., Bekkers, R. L. M., Vorst, M. J. D. L. V. D., Huijben, A. M. T., Baalbergen, A., Voogdt, K. G. J. A., Verhoeven, L., Smedts, H. P. M., Weber, K., Hazelbag, H. M., Bosse, T., Meerten, E. L. V. P., Kroon, C. D. D., Price, L., Vader, W., Kroep, J. R., & Ottevanger, N. P. B. (2025). Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer. npj Precision Oncology. https://doi.org/10.1038/s41698-025-01080-8

Source records

crossref · retrieved 2026-09-27T05:57:20.293Z